2023 Australia Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers

2023 Australia Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source, including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products by test.

ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.

The companies analyzed in this report include:

Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Cepheid/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
CellSearch
Clinical Genomics
Decode Genetics
DiaSorin
Diazyme
Eiken Chemical
Elitech Group
Enzo Biochem
Epigenomics
Erba Mannheim
Exact Sciences
Fujifilm Wako
Fujirebio
Grifols
GSK
Guided Therapeutics
Hologic
Janssen Diagnostics
Kyowa Medex
Labcorp
Leica Biosystems
Lonza
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
PerkinElmer
Polymedco
Qiagen
Quest Diagnostics
Roche
Scienion
Siemens Healthineers
Takara Bio
Theradiag
Thermo Fisher
Tosoh

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.